Tech Company Financing Transactions
Francis Medical Funding Round
Francis Medical closed a $55 million Series B financing round on 9/17/2021. Investors included Solas Bioventures, Arboretum Ventures and Coloplast.
Transaction Overview
Company Name
Announced On
9/17/2021
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer, scheduled to begin enrollment in August 2022.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Ln. N. 130
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
Francis Medical is developing novel, disruptive therapeutic solutions to treat prostate, kidney and bladder cancer. Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer, yet gentle on patients. Our work is fueled by a compassionate belief that cancer can be stopped with minimally invasive treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Kujak
Chief Technical Officer
Michael Hoey
VP - Finance
Michael Fredrick
VP - Marketing
Richard Hill
VP - R & D
David Francischelli
VP - Regulatory Affairs
Joel Phillips
VP - Regulatory Affairs
Michele Shepard
Browse more venture capital transactions:
Prev: 9/17/2021: Stardust venture capital transaction
Next: 9/17/2021: Outer venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs